Company Details
- Employees
- 72
- Founded
- -
- Address
- De Lismortel 31, Eindhoven,north Brabant 5612 Ar,netherlands
- Phone
- 41442697979
- in****@****tis.com
- Industry
- Medical Device
- Website
- xeltis.com
- Keywords
- Designer jobs.
- HQ
- Eindhoven, North Brabant
Please complete the CAPTCHA to continue
Sarasota Memorial Participates in Research Study Testing aXess™ Dialysis Conduit Florida Hospital News and Healthcare Report
Xeltis prepares for commercial launch after strong aXess trial results PharmaTimes
Xeltis has positive vascular access device data MassDevice
Xeltis reports preliminary data for Xabg coronary artery bypass conduit Medical Device Network
Xeltis sees encouraging preliminary data for Xabg coronary artery bypass conduit BioWorld MedTech
Xeltis wins FDA breakthrough status, enrols first patient in pivotal trial Clinical Trials Arena
Axelera AI and Xeltis secure EU scaleup funding ioplus.nl
Xeltis Receives IDE Approval from FDA for Initiation of US Pivotal Trial for aXess, its Restorative Vascular Access Conduit Diagnostic and Interventional Cardiology
Xeltis reports positive data for coronary bypass conduit MassDevice
Q&A: Xeltis implants first restorative hemodialysis graft in humans Healio
Xeltis Starts First-Ever Pivotal Trial of Its Synthetic Restorative Pulmonary Valve Medical Device and Diagnostic industry
Xeltis presents six-month first-in-human data on aXess graft Vascular News
Xeltis to advance heart valve programs Eindhoven University of Technology
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient Diagnostic and Interventional Cardiology
Xeltis starts pivotal clinical trial of “first-ever” restorative synthetic haemodialysis access graft Vascular News
Xeltis lands €32 million investment to develop restorative cardiovascular devices Eindhoven University of Technology
Xeltis’ vascular Axess graft implant sees no infection after one year BioWorld MedTech
Xeltis wins FDA IDE approval for restorative vascular access conduit pivotal trial MassDevice
Two-Year Xeltis Bioabsorbable Valve Data Shows Positive Functionality Diagnostic and Interventional Cardiology
First Bioresorbable Heart Valves Implanted to Enable Cardiovascular Restoration Diagnostic and Interventional Cardiology
Another major investment round for Xeltis: €32 million for the development of restorative cardiovascular devices ioplus.nl
Xeltis lands $52M for restorative heart valve technology Fierce Biotech
Cell-Based, Cell-Free Patches for Cardio Repair Genetic Engineering and Biotechnology News
Xeltis Develops First Ever Bio-Absorbable Heart Valve Med Device Online
2 +441223XXXXXX
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.